Live from the NIH registry
Studies recruiting near El Paso right now
Top 25 of 187 recruiting studies, sorted by proximity — each links to its official registry page
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Texas Arthritis Center, PA — El Paso, Texas (7.0 mi)
· Sponsor: University of Alabama at Birmingham
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
El Paso Children's Hospital — El Paso, Texas (7.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Phase 2
Interventional 465 participants sought
Davita Clinical Research — El Paso, Texas (7.0 mi)
· Sponsor: Novo Nordisk A/S
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
El Paso Pulmonary Association — El Paso, Texas (7.0 mi)
· Sponsor: Philip Morris Products S.A.
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Peripheral Arterial Disease
N/A
Observational 14,000 participants sought
El Paso Cardiovascular Care — El Paso, Texas (7.0 mi)
· Sponsor: Baylor Research Institute
rTMS for Military TBI-related Depression
Depressive Symptoms, Mild Traumatic Brain Injury
N/A
Interventional 198 participants sought
William Beaumont Army Medical Center — Fort Bliss, Texas (2.6 mi)
· Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Renovatio Clinical - El Paso — El Paso, Texas (7.0 mi)
· Sponsor: Hoffmann-La Roche
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
Severe Alopecia Areata
Phase 3
Interventional 300 participants sought
3A Research - East location /ID# 283404 — El Paso, Texas (7.0 mi)
· Sponsor: AbbVie
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
El Paso Children's Hospital — El Paso, Texas (7.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Academy of Diabetes, Thyroid and Endocrine /ID# 255735 — El Paso, Texas (7.0 mi)
· Sponsor: AbbVie
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
Phase 1, Phase 2
Interventional 340 participants sought
Renovatio Clinical - El Paso — El Paso, Texas (7.0 mi)
· Sponsor: Inhibrx Biosciences, Inc
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Texas Oncology - West Texas — El Paso, Texas (7.0 mi)
· Sponsor: Pfizer
Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?
Migraine
EARLY/Phase 1
Interventional 84 participants sought
University Medical Center of El Paso — El Paso, Texas (7.0 mi)
· Sponsor: Texas Tech University Health Sciences Center, El Paso
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
3A Research Llc West Location — El Paso, Texas (7.0 mi)
· Sponsor: Incyte Corporation
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
Nephritis, Lupus, Lupus Erythematosus, Systemic
Phase 3
Interventional 300 participants sought
Texas Arthritis Center — El Paso, Texas (7.0 mi)
· Sponsor: Viatris Innovation GmbH
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
MedResearch, Inc — El Paso, Texas (7.0 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Hypertriglyceridemia
Phase 3
Interventional 869 participants sought
Research Site 27 — El Paso, Texas (7.0 mi)
· Sponsor: Arrowhead Pharmaceuticals
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
David Turbay, MD — El Paso, Texas (7.0 mi)
· Sponsor: Amgen
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
El Paso Children's Hospital — El Paso, Texas (7.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 34 — El Paso, Texas (7.0 mi)
· Sponsor: Merus B.V.
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Agitation, Alzheimer Disease
Phase 2
Interventional 120 participants sought
ANESC Research — El Paso, Texas (7.0 mi)
· Sponsor: Celgene
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Heart Failure and Impaired Kidney Function
Phase 3
Interventional 4,800 participants sought
Research Site — El Paso, Texas (7.0 mi)
· Sponsor: AstraZeneca
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
El Paso Eye Surgeons /ID# 268356 — El Paso, Texas (7.0 mi)
· Sponsor: AbbVie
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
David Turbay, MD — El Paso, Texas (7.0 mi)
· Sponsor: Amgen
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
Phase 2, Phase 3
Interventional 300 participants sought
GSK Investigational Site — El Paso, Texas (7.0 mi)
· Sponsor: GlaxoSmithKline